DESIGN AND EVALUATION OF FAST DISSOLVING ORO-DISPERSIBLE FILMS OF METOCLOPRAMIDE HYDROCHLORIDE USING 32 MULTIFACTORIAL DESIGNS
Keywords:
Keywords, Fast dissolving oro-dispersible films, Optimization, Metoclopramide HCL, 32multifactorial designs, NilAbstract
Objective: The objective of the present work was to develop and optimize fast dissolving orodispersible films containing metoclopramide hydrochloride using 32 multifactorial designs.
Methods: The films were prepared by solvent casting method using hydroxypropyl methyl cellulose E5 (HPMC E5) and sodium starch glycolate (SSG) as two independent variables in three levels in concentration 2.5, 3, 3.5% w/wand 1, 1.5, and 2 % respectively. The percent of in vitro drug release (Y1) and the disintegration time (Y2) were chosen and studied as dependent responses. The prepared films were also evaluated for their weight uniformity, thickness, surface pH, drug content, in vitro disintegration time, in vitro drug release, film stability and mechanical properties as folding endurance.
Results: All the films were transparent. The films weight (mg) was ranging from 63±0.78 to 86±0.82 while the film thickness (mm) and the folding endurance range from 0.22±0.53, 50±0.58 to 0.32±0.35 and 90±0.84 respectively. The drug content (mg %) was studied, and it ranges from 98.24±1.08 to 99.07±1.02. It was found that the relative standard deviation (% RSD) met the criteria of USP specification for drug content (>6%). In vitro disintegration time was tested; all films satisfied the requirement of disintegration time for fast dissolving dosage form (>1 min), it ranged from 2.24±1.75 to 3.18±1.87 sec. The stability studies revealed no significant differences before and after storage for the all formulations.
Conclusion: An optimized metoclopramide HCl film was achieved that could be a benefit to a patient suffering from emesis, in which hydroxypropyl methylcellulose (E5) was used as a film forming polymer in its high level (3.5%) in addition to sodium starch glycolate in its high level (2%).
Keywords: Fast dissolving orodispersible films, Optimization, Metoclopramide HCL, 32multifactorial designs
Downloads
References
Al-Hezaimi K, Al-Askar M, Selamhe ZF JH, Alsarra IA, Wang HL. Evaluation of novel adhesive film containing ketorolac for post-surgery pain control: a safety and efficacy study. Periodontal 2011;82:963-8.
Vasisht N, Gever LN, Tagarro I, Finn AL. Single-dose pharmacokinetics offentanylbuccal soluble film. Pain Med 2010;11:1017-23.
Finn AL, Hill WC, TagarroI, Gever LN. Absorption and tolerability of fentanyl buccalsoluble film (FBSF) in patients with cancer in the presence of oral mucositis. J Pain Res 2011;4:245-51.
Nishimura M, Matsuura K, Tsukioka T, Yamashita H, Inagaki N, Sugiyama T, et al. In vitro and in vivo characteristics of prochlorperazine oral disintegratingfilm. Int J Pharm 2009;98:102-368.
Kunte S, Tandale P. Fast dissolving strips: a novel approach for the delivery of verapamil. J Pharm BioAllied Sci 2010;2:325–8.
Arya A, Handra A, Sharma V, Pathak K. Fast dissolving oral films: an innovative drug delivery and dosage form. Int Chem Technol Res 2010;2:576-83.
Kelly HW, Murphy S. Beta-adrenergic agonists for acute severe asthma. Ann Pharmacother 1992;26:81-91.
Patel RS, Poddar SS. Development and characterization of mucoadhesivebuccal patches of salbutamol sulphate. Curr Drug Delivery 2009;6:140-4.
Olsson A, Sheng Y, Kjellen E, Pero RW. In vivo tumor measurement of DNA damage, DNA repair and DNA pools as indicators of radiosensitization by metochlopramide. Carcinogenesis 1995;16:1029-35.
Dollery C. Therapeutic drugs. 2nd ed. Churchill livingstone, Toronto; 1999. p. M132-M136.
Harrington RA, Hamilton CW, Brogden RN. Metoclopramide an updated review of its pharmacological properties and clinical use. Drugs 1983;25:451-94.
Cilurzo F, Cupone IE, Minghetti P, Selmin F, Montanari L. Fast dissolving films made of maltodextrins. Eur J Pharm Biopharm 2008;70:895-900.
Mashru RC, Sutariya VB, Sankalia MG, Parikh PP. Development and evaluation of fast-dissolving film of salbutamol sulphate. Drug Dev Ind Pharm 2005;31:25-34.
Mahesh A, Shastri N, Sadanandam M. Development of taste masked fast disintegrating films of levocetirizine-dihydrochloride for oral use. Curr Drug Delivery 2010;7:21-7.
Choudhary D, Patel V, Patel H. Formulation and evaluation of quick dissolving film of levecetrizine di hydrochloride. Int J Pharm Technol 2011;3:1740-9.
USP30-NF25, the United States Pharmacopoeia-National Formulary and its supplements; 2007.
Hoffmann EM, Breitenbach A, Breitkreutz J. Advances in orodispersible films for drug delivery. Expert Opin Drug Delivery 2011;8:299-316.
Misra R, Amin A. Formulation development of taste-masked rapidly dissolving films of citrizine hydrochloride. Pharm Technol 2009;33:48-56.
Vasantha PV, Puratchikody A, Mathew ST, Balaraman AK. Development and characterization of Eudragit based mucoadhesivebuccal patches of salbutamol sulfate. Saudi Pharm J 2011;19:207-14.
Hema Chaughary, Samita Gauri, Permender Rathee, Vikash Kumar. Development and optimizationof fast dissolving oro-dispersible films of granisetron HCl using Box-Behnken statistical design. Bull Faculty Pharm Cairo University 2013;51:193-201.
Hill SW, Varker AS, Karlage K, Myrdal PB. Analysis of drug content and weight uniformity for half-tablets of 6 commonly split medications. J Manag Care Pharm 2009;15:253-61.
Raju S, Sandeep Reddy P, Anirudh Kumar V, Deepthi A, Sreeramulu Reddy K, Madhava Reddy PV. Flash release oral films of metoclopramide hydrochloride for pediatric use: formulation and in vitro evaluation. J Chem Pharm Res 2011;3:636-46.
Kumar P, Kumar S, Kumar A, Chander M. Physicochemical characterization of solid dispersion of cefdinir with PVP K-30 and PEG4000. Int J Pharm Sci Nanotechnol 2010;3:948-56.
Patel T, Patel LD, Patel T, Makwana S, Patel T. Enhancement of dissolution of fenofibrate by solid dispersion technique. Int Res Pharm Sci 2010;1:127-32.